| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.6 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |